Microbot Medical (MBOT) Operating Expenses (2010 - 2026)

Microbot Medical's Operating Expenses history runs 17 years deep, the most recent figure standing at $557000.0 for Q1 2026.

• Quarterly Operating Expenses rose 7.32% year-over-year to $557000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 4.62% YoY) and the FY2025 annual result came in at $2.8 million, up 7.79% from the prior year.
• Operating Expenses was $557000.0 for Q1 2026 at Microbot Medical, down from $4.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $4.9 million in Q4 2025 and bottomed at -$1.0 million in Q2 2025.
• A 5-year average of $1.8 million and a median of $2.3 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses plunged 127.45% — and 2025, when it jumped 188.57%.
• Microbot Medical's Operating Expenses stood at $3.1 million in 2022, then slumped by 32.59% to $2.1 million in 2023, then surged by 111.07% to $4.4 million in 2024, then grew by 12.9% to $4.9 million in 2025, then slumped by 88.7% to $557000.0 in 2026.
• Business Quant data shows MBOT's Operating Expenses at $557000.0 in Q1 2026, $4.9 million in Q4 2025, and -$635000.0 in Q3 2025.